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Abstract
Background: The sexually transmitted infection gonorrhea remains a public health concern for becoming resistant
to drug treatments available. The purpose of this study was to evaluate the usefulness of the matrix-assisted laser
desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) to identify and cluster Neisseria
gonorrhoeae.
From a current monitoring in Italy, as part of the European Gonococcal Antimicrobial Surveillance
Programme (EURO-GASP), 93 gonococci collected from 2007 to 2012 susceptible (44 isolates) and resistant
(49 isolates) to cefixime were selected. Minimum Inhibitory Concentration (MIC) values for cefixime was
assessed by Etest carried out in agreement with the manufacturer’s instructions and interpreted referring to
European Committee on Antimicrobial Susceptibility testing (EUCAST) clinical breakpoints criteria. Data
obtained by N. gonorrhoeae multiantigen sequence typing (NG-MAST) and the dendrogram based on the
concatenation of porB and tbpB genes were evaluated. MALDI-TOF MS, to reconfirm gonorrhea identification,
analyzed single colonies from freshly grown isolates and applied directly on a ground-steel MALDI target
plate. For the MALDI-TOF dendrogram cluster analysis, MSPs (Main Spectrum Profile) from each isolate were
created acquiring 5000 shots from 10 technical replicates obtained from bacteria extraction.
Results: Molecular typing by NG-MAST showed 28 sequence types (STs); G1407 was the predominant
accounting for 75 gonococci. All the 93 gonococci, except one, were correctly identified at species level by
MALDI-TOF MS and G1407 isolates were divided into two clusters.
Conclusion: MALDI-TOF MS for a real-time detection and cluster analysis of gonorrhea is a promising tool
for surveillance purposes. Moreover, additional studies are required to collect more data on the performance
of MALDI-TOF MS for gonococci.
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Background
Neisseria gonorrhoeae is responsible for causing gonor-
rhea, one of the most common bacterial sexually trans-
mitted disease worldwide, affecting 106 million people
each year [1]. Although significant progress was made in
reducing the incidence of the disease, gonorrhea infection
is becoming a much more difficult to treat, increasing
morbidity and medical cost [2–4]. In recent years, the
emergence of multi-drug resistant (MDR) N. gonorrhoeae
is a serious problem for treatment options [3, 5–7]. In par-
ticular, as reported by the European Centre for Disease
Prevention and Control (ECDC), the proportion of gono-
cocci with reduced susceptibility to cefixime, was 5.1 % in
2009 and 7.6 % in 2011, respectively [3, 8]. Sporadic cases
due to ceftriaxone-resistant isolates have also been de-
scribed in Europe [9, 10].
Surveillance of antimicrobial resistance (AMR) and
MDR gonorrhea, promoting susceptibility testing and
studying the genetic mechanism of resistance, is a key
point for the control strategy and to combat the spread
of resistant gonococci [10–14].
In this regard, the rapid diagnosis and typing should
be pursued to enhance surveillance capabilities [15–17].
Currently, one of the reference method for gonor-
rhea typing is the N. gonorrhoeae multiantigen se-
quence typing (NG-MAST). Many reports highlight
the NG-MAST highly discriminatory power, reprodu-
cibility, speed, low cost and easy to perform; a public
database [http://www.ng-mast.net] for analysis and as-
signment of the allele numbers and Sequence Type
(ST) is available, [15, 17]. Nowadays, the ST1407, the
main ST together with all the related STs, defined the
Genogroup (G) 1407 [14–16]. Gonococci belonging to
ST1407, mainly associated with reduced susceptibility
and resistance to third generation cephalosporins, are
spreading in Europe [13–16] and worldwide [18]. In
2011, it was noted in 20/21 European countries and
the association among ciprofloxacin resistance, de-
creased susceptibility to cefixime and G1407 has been
observed [15]. Moreover, isolates belonging to G1407
with an increased minimum inhibitory concentrations
(MICs) to ceftriaxone and azithromycin, have also
been reported [15]. Overall, the identification of a
specific genogroup may predict patterns of antimicro-
bial resistant among circulating gonococci [16]. Re-
cently, the identification by the matrix-assisted laser
desorption ionization-time of flight mass spectrom-
etry (MALDI-TOF MS) has revolutionized the work-
flow of microbiology laboratories [19, 20], because of
its capability to quickly identify bacterial species and
yeasts accurately in comparison with conventional
methods [21, 22]. Nowadays, MALDI-TOF MS is
considered a reliable tool for the detection and typing
of bacteria [23–25].
The purpose of this study was to evaluate the use-
fulness of MALDI-TOF MS to identify and cluster
Neisseria gonorrhoeae.
Methods
N.gonorrhoea isolates, microbiological methods and
patients
Primary isolation, identification and collection, following
standard microbiological procedures of 93 gonococci,
collected from 2007 to 2012, were performed by the
Collaborating Laboratories belonging to Universities,
Sexual Transmitted Infectious (STI) and Dermatology-
Venereology (DV) Clinics. Routine diagnostic testing
consisted with culture of N. gonorrhoeae from clinical
samples (i.e. urethral exudate) inoculating directly on
Thayer-Martin medium (Oxoid Ltd, Milan, Italy) with
1 % IsoVitalex (Oxoid, Hampshire, United Kingdom)
at 37 °C in a 5 % CO2 atmosphere. Identification was
carried out mainly by using API NH system gallery
(bioMérieux, Hantverksvägen, Sweden). Isolates were
sent to the Istituto Superiore di Sanità (ISS) for stor-
age - 80 °C and further microbiological investigations.
Antimicrobial susceptibility tests were performed fol-
lowing the European Gonococcal Antimicrobial Surveil-
lance Programme (EURO-GASP), [26]. In particular,
antimicrobial susceptibility to cefixime, was assessed by
Etest (bioMérieux, Hantverksvägen, Sweden) in agree-
ment with the manufacturer’s instructions. MIC values
were interpreted referring to European Committee on
Antimicrobial Susceptibility testing (EUCAST) clinical
breakpoint criteria (S ≤ 0.125 mg/L; R > 0.125 mg/L),
(version 5.0, 2015), [27]. The World Health Organization
(WHO) N. gonorrhoeae G, K, M, O, and P control
strains were used in each test [28]. The 93 gonococci
were selected referring to antimicrobial susceptibiltiy to
cefixime; in particular, 44 isolates were susceptible and
49 resistants. No patient identification was available at
the ISS. The isolates were collected for surveillance pur-
poses, thus this work was considered for public health
practice, as routine in clinical setting, and no ethical
approval was required.
NG-MAST analysis
Chromosomal DNA was extracted using the QIAamp
DNA minikit (Qiagen, Hilden, Germany) according to
the manufacturer’s instructions. For NG-MAST analysis,
sequence of porB and tbpB genes were performed using
primers and amplification parameters, as previously de-
scribed [29]. The porB and tbpB alleles were assigned at
the NG-MAST website (http://www.ng-mast.net), fol-
lowing the interpretative criteria [29]. Closely related
STs were clustered using published definitions [15, 16].
In particular, all STs which shared one allele and
showed >99 % similarity in the other allele (≤5 bp
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difference for porB and ≤4 bp for tbpB), were included
in the same genogroup [15].
NG-MAST data were analyzed by Unweighted Pair
Group Mean Average (UPGMA) clustering method
using MEGA software (version 5.2, http://www.mega-
software.net); the distance matrices were based on a
bootstrap test of 500 replicates; the evolutionary dis-
tances were computed using the Tajima-Nei method and
visualized as a dendrogram.
MALDI-TOF MS and data analysis
For MALDI-TOF MS identification, single colonies from
freshly grown isolates were picked and directly applied
in duplicate on a ground-steel MALDI target plate. One
microliter of a saturated solution of α-cyano-4-hydroxy
cinnamic acid, HCCA (Bruker Daltonik, Bremen,
Germany) matrix was deposited on the sample tested
and allowed to co-crystallize at room temperature.
Spectra useful for identification were recorded in posi-
tive linear mode by a Microflex LT mass spectrometer
with a laser frequency of 20 Hz; ion source 1 and 2 volt-
age, 20 kV and 16.7 kV respectively; lens voltage, 8.5 kV
After the automatic acquisition spectra were identified
by MALDI Biotyper RTC software, database version 3.1
(4613 entries). For instrument calibration bacterial test
standard BTS255343 from Bruker Daltonics it has been
used. For the evaluation of the identification results we
adopted criteria suggested by the manufacturer; briefly,
score values below 1.7 indicated a not reliable identifica-
tion, between 1.7 and 1.99 a probable genus identifica-
tion and equal or above 2.0 a secure genus identification
and probable or highly probable species identification
(between 2.0 - 2.29 and above 2.3, respectively). For the
MALDI-TOF dendrogram, 93 MSP (Main Spectrum
Profile) of the N. gonorrhoeae isolates were created to
acquire at least 20 separate spectra obtained from 240
shots for a total of above 5000 shots from 10 technical
replicates from bacteria extraction with formic acid and
acetonitrile, as reported by manufacturer [30]. Quality
control peaks was performed using flexAnalysis software
(Version 3.3); spectra with outlier peaks or anomalies
were removed from the set of the isolate; peaks from
3000 to 10,000 Da were selected and checked so that the
allowed difference between the smallest and the largest
mass was always lower than 500 ppm. Software settings
for MSP creation were those suggested by the Bruker
Biotyper 3.1 Version [31]. Reproducible spectra profiles
was assessed by composite correlation index analysis
(CCI) as a representative value of around high conform-
ance of the spectra [32] The hierarchical cluster analysis
was performed with the integrated statistical tool Matlab
7.1 of the BioTyper 3.0 software package using default cor-
relation function. Basing on the values obtained from the
pairwise comparison of different spectra, a dendrogram




The molecular typing identified 28 STs out of the 93
isolates. Figure 1 shows the STs found among G1407. In
particular, ST1407 was found in 57 isolates (61.3 %),
with porB908 and tbpB110 alleles. According to the gen-
ogroup definition, and basing on sequence similarity of
the porB and tbpB alleles, ST 2212, 4359, 3499, 8096,
4973, 5570, 7050, 4974, 5335 and 8095 were included in
G1407 (75 isolates). The remaining 18, showed different
STs, as singletons, except for two belonging to the same
ST5339. Out of 18 isolates, 6 belonged to 3 different
Fig. 1 Neisseria gonorrhoeae multiantigen sequence typing
(NG-MAST) of 93 gonococci isolated from 2007 to 2012 in Italy
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genogroups, according to the definition [15]: G225,
G4238, G4517 (Fig. 1).
Figure 2 shows the similarity obtained from tbpB and
porB sequences detected in all the isolates.
MALDI-TOF MS analysis
MALDI-TOF MS allows to correctly identify, at the
species level all the 93 isolates, of which 30.1 % with
excellent score values (above 2.3); while one isolate was
identified at genus level only (with a score of 1.987). The
latter was resistant to cefixime and belonging to G1407.
One minute per sample was the time estimated from
the picking of the colony to obtain the identification
results at the species level and 30 cents the cost per
sample [21].
As shown in Fig. 3, in relation to their mass signals
and intensities, a hierarchic dendrogram clustered the
93 gonococci in two main groups: a large group (n = 77
isolates) it has been divided into two sub-clusters, the
remaining 15 isolates were grouped into a smaller one.
Conversely, 1 single isolate was grouped in a different
cluster, according to the arbitrary distance level of 600
(Fig. 3). Dendrograms obtained from MALDI-TOF MS
hierarchical cluster analysis and concatenation of tbpB
and porB sequences were compared; the G1407 clus-
tered as a single clone by NG-MAST, whilst turn to be
divided in two groups by dendrogram obtained with
MALDI-TOF MS analysis. In particular, in one cluster
have been included isolates belonging to G1407 except
for one that had the ST4232 with the tbpB allele 110
present among the G1407 isolates. In the second cluster,
60 out of 77 isolates belonged to G1407. The remaining
17 isolates defined small groups of 2 isolates, i. e. ST225
and ST5107 or ST4517 and ST4518 (Fig. 3).
Discussion
Gonorrhea is considered the most common bacterial
sexually transmitted infection and remains a public
health concern due to the spread of antimicrobial resist-
ance [3, 6, 33]. As typing tool, NG-MAST, is routinely
Fig. 2 Phylogenetic tree obtained with Unweighted Pair Group Mean Average (UPGMA) clustering method using MEGA software [version 5.2;
http://www.megasoftware.net] showing the relatedness of both porB and tbpB alleles (NG-MAST analysis) for 93 N. gonorrhoeae isolates. Circles
indicate Sequence Types (STs) belonging to genogroup (G)1407
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used for the investigation of molecular epidemiology of
gonococci as the reference method [14, 16, 34, 35].
Thus, it refers to the sequence variations in two hyper-
variable loci, porB and tbpB, coding for the gonococcal
outer membrane porin and the β-subunit of the
transferrin-binding protein, respectively [15, 29]. Fur-
thermore, it is considered the current method of
choice and widely used to identify the route of trans-
mission [15]; several studies have shown a relationship
between the NG-MAST and antimicrobial susceptibil-
ity profiles [10, 13, 14, 16, 34, 35].
Over the past few years, MALDI-TOF MS has be-
come widely used for the rapid identification and typing
of yeast and bacterial species in the clinical microbiol-
ogy laboratory [23–25]. MALDI-TOF MS identification
is based on the differences of whole cell proteins, which
are mainly ribosomal proteins, by matching against a
database.
In this study we evaluated the ability of MALDI-TOF
MS for the rapid identification and cluster of gonococci
particularly those belonging to G1407, the genogroup
primarly associated with cefixime resistance. This clonal
group represented the largest group in our study. Beyond
this, gonococci were correctly identified by MALDI-TOF
MS at the species level, except one, at the genus level only,
with a score very close to the cut-off of 2.0. Compared to
conventional biochemical methods used for the identifi-
cation, mass spectrometry can be performed in few mi-
nutes. Further analysis would be required in order to
evaluate the use of MALDI-TOF MS for diagnosis dir-
ectly on clinical sample.
Moreover, the performance of MALDI-TOF MS for
clustering of 93N. gonorrhoeae isolates, already analysed
by NG-MAST, were evaluated as a complement typing
method, in particular for screening purposes.
The results showed that all the investigated gonococci
were highly related and that those belonging to G1407
were divided into two distinct clusters by MALDI-TOF
MS. Although, NG-MAST and MALDI-TOF mass spec-
trometry rely on quite different approaches, genome and
proteome analysis respectively, the results suggest a role
for MALDI-TOF MS for at least gonorrhoea identification.
Nevertheless, as it is possible to argue, from the compari-
son between NG-MAST and MALDI-TOFdendrograms,
not a reliable use for N. gonorrhoeae genotyping is attribut-
able to the latter technique, even if inside the same gen-
ogroup, as identified by NG-MAST, the MALDI TOF MS
clustered the isolates in more groups. In this context, we
Fig. 3 Cluster analysis of MALDI-TOF MS spectra obtained for 93 N. gonorrhoeae isolates. In the MSP dendrogram, relative distance between
isolates is displayed as arbitrary units. Zero indicates complete similarity and 1000 indicates complete dissimilarity. The arbitrary distance level of
600 was chosen for isolates clustering evaluation. The STs listed in the Figure are different from the genogroup (G) 1407
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would like to mention the recent minireview by Spinali
et al. [36]. In that article, it is well summarized the need to
share guidelines for interpreting the data as already estab-
lished for other techniques as Pulsed-field gel electrophor-
esis (PFGE). Furthermore, the potential of MALDI-TOF
MS for typing purposes is contradictory from many exam-
ples, from E. faecium to L. pneumophila, [36].
Overall, some benefits may be attributed to the use of
MALDI-TOF MS: the short time for the identification
the low cost, the limited number of colonies needed in
comparison with conventional methods.
Conclusion
In summary the results are promising to consider
MALDI-TOF MS for real-time identification of N.
gonorrhoeae at the species level, with a reduction of
time, consumables and skilled personnel compared to
conventional methods. Finally, mass spectrometry ap-
proach needs to be further evaluated for gonorrhea typ-
ing purposes, even if a potential ability to discriminate
among isolates belonging to the same genogroup was
evinced.
Availability of supporting data
The matrix obtained from the alignment of 93N. gonor-
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phylo/treebase/phylows/study/TB2:S17893.
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